Csaba Poroszlai is confirmed CEO of the company by the Board of Directors of Egis. Balázs Vándor is appointed to the position of the Company’s Chief Financial Officer.

Following the success of Egis Russia and Egis Polska, we are proud to announce that Egis Praha has also been recognized as Best Employer at Aon Hewitt’s Employee Engagement Survey.

Egis has developed a new procedure for the dehalogenation of technological wastewaters. In 2018, the Swedish Chamber of Commerce in Hungary recognized the innovation with the Gran Prize Interdisciplinary Innovative award.

Hungarian-based Egis Pharmaceuticals PLC signed an exclusive distribution agreement with Mundipharma network for a pegfilgrastim biosimilar. Pursuant to the agreement, Egis gains the exclusive distribution rights related to the medicine used to reduce a common side effect of cancer treatment called neutropenia and the related life-threatening infections. Thus, Egis gets the opportunity to launch this pegfilgrastim biosimilar product in four Eastern European countries.

PharmaBoardroom is a site for senior professionals, providing global news, trends and reports relating to the pharmaceutical industry.

EGIS Polska team among 5 winners of the first edition of International Digital Idea Challenge EGIS.

May this joyful season of Easter fill your heart with renewed hope, love and peace. Happy Easter!

Wishing you Good Vibes for Christmas and Every Happiness in the Coming 2022 Year!

Wish you all a Happy, Healthy and Peaceful Easter!

Today on 23rd March, we celebrate the Polish-Hungarian Friendship Day. We send our best wishes to our Hungarian colleagues and all lovers of Hungary. Poles and Hungarians have been bound by a close friendship for years. Let us wish that the historical slogan "Pole, Hungarian, two nephews" will never lose its validity. Minden jót!